Market
Synopsis of the Global Nonallergic Rhinitis Market
Rising prevalence of nonallergic
rhinitis, and increasing demand for diagnosis and treatment of nonallergic
rhinitis are the major factors driving the growth of the market across the
globe. Furthermore, increasing healthcare expenditure and overall growth of
healthcare industry also influences the market growth. Splendid research in the
field of immunology also boost the market. Additionally, increasing focus on
the development of new medications for the treatment of nonallergic rhinitis,
and increasing use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) also fuel
the market growth.
The Nonallergic Rhinitis Market growth
of the market is restricted by increasing competition among key players in the
market that act as a barrier of new entrants. The Global Nonallergic Rhinitis Market
report is a professional in-depth analysis report which explores detail
overview of some of the key players in this market which are Boehringer
Ingelheim GmbH (Germany), Novartis (U.S.), GlaxoSmithKline (U.K), Perrigo
Company plc (Ireland), Johnson & Johnson Consumer Inc. (U.S.), Bayer
(U.S.), Sanofi (France) and others.
The
global nonallergic rhinitis market is expected to grow at a CAGR of 5.3% during
the forecast period.
Key Players in the Global Nonallergic Rhinitis
Market
·
Boehringer
Ingelheim GmbH (Germany)
·
Novartis
(U.S.)
·
GlaxoSmithKline
(U.K)
·
Perrigo
Company plc (Ireland)
·
Johnson
& Johnson Consumer Inc. (U.S.)
·
Bayer
(U.S.)
·
Sanofi
(France)
Regional
Analysis of the Global Nonallergic Rhinitis Market
America
holds the first position in the market for nonallergic rhinitis owing to the
rising prevalence of nonallergic rhinitis in the U.S., and consequent increase
in the demand for new diagnostic and treatment services. In Americas, North
America is the largest market owing to the presence of key players in the
industry. As per the Warren Alpert Medical School of Brown University, the
prevalence of nonallergic rhinitis has been observed to be one-third that of
allergic rhinitis, affecting ~7% of the U.S. population or ~22 million people.
Additionally, rising awareness about morbidity due to nonallergic rhinitis and
the presence of key players in the market also influence the growth of the
market.
The
Middle East & Africa also show a steady rise in the market owing to low
prevalence of nonallergic rhinitis and increasing awareness about allergic and
nonallergic rhinitis treatment. In the Middle East & Africa, the Middle
East captures the largest market share for availability of specialty medical
services and increasing expenditure on healthcare
Europe is
the second largest market for nonallergic rhinitis. In Europe, there is an
increasing demand for nasal sprays, and extensive research and development
activities by clinical research and academic institutes for chronic diseases
treatment. Germany, and France are the largest contributors to the market
growth owing to an increase in the number of market players manufacturing
NSAIDs, and overall growth of healthcare industry.
The
market in Asia Pacific is expected to grow at the fastest pace and is driven by
an increasing number of patients suffering from nonallergic rhinitis and
increasing awareness about the diagnosis and treatment. India, China, and Japan
are major contributors to the growth of the market. This growth is attributed
to an increasing demand for nasal sprays and OTC medicines and availability of
highly qualified medical personnel dedicated to the research of chronic diseases.
Segments
The global nonallergic rhinitis market is segmented
on the basis of diagnosis, treatment, and end user.
On the
basis of diagnosis, market is categorized into physical examination, allergy
testing, imaging test, and other segments. Allergy testing is further segmented
into skin test and blood test. Imaging test is further segmented into nasal
endoscopy, and computerized tomography (CT) Scan.
Nasal
sprays is further segmented into saline, corticosteroid, antihistamine,
decongestants, and anti-drip anticholinergic.
On the
basis of end user, the market is segmented into hospitals & clinics,
research centers, and others.
On the basis
of treatment, the market is segmented into nasal sprays, NSAIDs and others.
Detailed Table
of Contents:
Table Of Contents
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6
Technology Trends & Assessment
11
Appendix
About US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment